Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial.
Jacobse J, Ten Voorde W, Tandon A, Romeijn SG, Grievink HW, van der Maaden K, van Esdonk MJ, Moes DJAR, Loeff F, Bloem K, de Vries A, Rispens T, Wolbink G, de Kam M, Ziagkos D, Moerland M, Jiskoot W, Bouwstra J, Burggraaf J, Schrier L, Rissmann R, Ten Cate R.
Jacobse J, et al. Among authors: burggraaf j.
Br J Clin Pharmacol. 2021 Aug;87(8):3162-3176. doi: 10.1111/bcp.14729. Epub 2021 Feb 2.
Br J Clin Pharmacol. 2021.
PMID: 33403697
Free PMC article.
Clinical Trial.